Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Targacept initiates phase I trial of TC-5214 in major depressive disorder

March 19, 2008

Studies point to lacosamide efficacy in painful diabetic neuropathy

March 18, 2008

Benefits lasting 6 months seen with duloxetine in fibromyalgia patients

March 18, 2008

Novel botulinum toxin type A treatment improves aspects of plantar fasciitis

March 18, 2008

Novel analgesic agents disclosed in recent Boehringer Ingelheim and GSK patents

March 18, 2008

Teva reports negative final results from a phase II trial of glatiramer acetate in ALS

March 18, 2008

Eisai submits application in Japan for oral jelly formulation of Aricept in Alzheimer's disease

March 18, 2008

GSK's novel NOS-2 inhibitor SB-823387 shows analgesic efficacy in experimental dental pain

March 17, 2008

Clinical Data initiates second of two phase III trials of vilazodone for depression

March 17, 2008

Urigen reports phase II study results with URG-101 in painful bladder syndrome

March 14, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...